Related references
Note: Only part of the references are listed.Moxifloxacin Population Pharmacokinetics in Patients with Pulmonary Tuberculosis and the Effect of Intermittent High-Dose Rifapentine
Simbarashe P. Zvada et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
gyrA mutations and phenotypic susceptibility levels to ofloxacin and moxifloxacin in clinical isolates of Mycobacterium tuberculosis
Frederick A. Sirgel et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial
Andreas H. Diacon et al.
LANCET (2012)
Metronidazole prevents reactivation of latent Mycobacterium tuberculosis infection in macaques
Philana Ling Lin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Comprehensive analysis of methods used for the evaluation of compounds against Mycobacterium tuberculosis
Scott G. Franzblau et al.
TUBERCULOSIS (2012)
Mycobacterium tuberculosis: success through dormancy
Martin Gengenbacher et al.
FEMS MICROBIOLOGY REVIEWS (2012)
Sterilizing Activity of Novel TMC207-and PA-824-Containing Regimens in a Murine Model of Tuberculosis
Rokeya Tasneen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
The challenge of new drug discovery for tuberculosis
Anil Koul et al.
NATURE (2011)
Activity of Drug Combinations against Dormant Mycobacterium tuberculosis
Perla Filippini et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Nitrate Respiration Protects Hypoxic Mycobacterium tuberculosis Against Acid- and Reactive Nitrogen Species Stresses
Mai Ping Tan et al.
PLoS One (2010)
The near future: Improving the activity of rifamycins and pyrazinamide
D. A. Mitchison et al.
TUBERCULOSIS (2010)
Assessment of the Effects of the Nitroimidazo-Oxazine PA-824 on Renal Function in Healthy Subjects
Ann M. Ginsberg et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Acid Resistance in Mycobacterium tuberculosis
Omar H. Vandal et al.
JOURNAL OF BACTERIOLOGY (2009)
Nitazoxanide Kills Replicating and Nonreplicating Mycobacterium tuberculosis and Evades Resistance
Luiz Pedro S. de Carvalho et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
The spectrum of latent tuberculosis: rethinking the biology and intervention strategies
Clifton E. Barry et al.
NATURE REVIEWS MICROBIOLOGY (2009)
Novel drug target strategies against Mycobacterium tuberculosis
Dennis J. Murphy et al.
CURRENT OPINION IN MICROBIOLOGY (2008)
Differentially expressed genes in Mycobacterium tuberculosis H37Rv under mild acidic and hypoxic conditions
Su-Young Kim et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2008)
Drugs versus bugs: in pursuit of the persistent predator Mycobacterium tuberculosis
James C. Sacchettini et al.
NATURE REVIEWS MICROBIOLOGY (2008)
PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release
Ramandeep Singh et al.
SCIENCE (2008)
Cytological and transcript analyses reveal fat and lazy persister-like bacilli in tuberculous sputum
Natalie J. Garton et al.
PLOS MEDICINE (2008)
A common mechanism of cellular death induced by bactericidal antibiotics
Michael A. Kohanski et al.
CELL (2007)
Metronidazole plus rifampin sterilizes long-term dormant Mycobacterium tuberculosis
Elisabetta Iona et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis
Sang Hyun Cho et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Identification of a nitroimidazo-oxazine-specific protein involved in PA-824 resistance in Mycobacterium tuberculosis
UH Manjunatha et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Preclinical testing of the nitroimidazopyran PA-824 for activity against Mycobacterium tuberculosis in a series of in vitro and in vivo models
AJ Lenaerts et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Anaerobic incubation conditions enhance pyrazinamide activity against Mycobacterium tuberculosis
MM Wade et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2004)
Mycobacterium tuberculosis from chronic murine infections that grows in liquid but not on solid medium
J Dhillon et al.
BMC INFECTIOUS DISEASES (2004)
Mycobacterium tuberculosis growth at the cavity surface:: a microenvironment with failed immunity
G Kaplan et al.
INFECTION AND IMMUNITY (2003)
Share Paper
